Cargando…
Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity
BACKGROUND: To evaluate the outcome of intravitreal bevacizumab (IVB) and aflibercept (IVA) injection for patients with retinopathy of prematurity (ROP). METHODS: In this single-center retrospective cohort, the recorded medical data of the infants who had been undergone intravitreal injection with e...
Autores principales: | Riazi-esfahani, Hamid, Mahmoudi, Alireza, Sanatkar, Mehdi, Farahani, Afsar Dastjani, Bazvand, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513371/ https://www.ncbi.nlm.nih.gov/pubmed/34645516 http://dx.doi.org/10.1186/s40942-021-00334-4 |
Ejemplares similares
-
Evaluation of Neurodevelopmental Outcomes in Premature Twins (Multigestations) with Retinopathy of Prematurity Receiving Anti-VEGF: A Comparison Study
por: Ghassemi, Fariba, et al.
Publicado: (2022) -
Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors
por: Bazvand, Fatemeh, et al.
Publicado: (2021) -
Hypertension and Ischemic Stroke After Aflibercept for Retinopathy of Prematurity
por: Bazvand, Fatemeh, et al.
Publicado: (2020) -
Prevalence and Risk Factors of Retinopathy of Prematurity in Iran
por: Zarei, Mohammad, et al.
Publicado: (2019) -
The Accuracy of Digital Imaging in Diagnosis of Retinopathy of Prematurity in Iran: A Pilot Study
por: Karkhaneh, Reza, et al.
Publicado: (2019)